Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bondronat vs Zoledronic Acid for Pain in Malignant Bone Disease
NCT00099177Phase 3Terminated
- Sponsor
- Roche
- Start
- Aug 2005
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of ibandronic acid in malignant bone neoplasm, sponsored by Roche. Started Aug 2005; status: terminated.
02
Drugs
ibandronic acid
03
Conditions
malignant bone neoplasm
Beyond the preview
Go deeper on NCT00099177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00099177.